Skip to content

Development and impact of a physician-nurse coordinator system on autologous hematopoietic stem cell transplantation timing in multiple myeloma

Development and impact of a physician-nurse coordinator system on autologous hematopoietic stem cell transplantation timing in multiple myeloma

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20251202010
Enrollment
72
Registered
2025-12-02
Start date
2024-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transplant eligible multiple myeloma patients Autologous hematopoietic stem cell transplantation Multiple myeloma

Interventions

The PNC system was established to streamline the pretransplant workup process. Dedicated physicians and nurses led this centralized operational unit, which was responsible for patient enrollment, admi
s preparation status, identify pending evaluations, and initiate prompt follow-up actions, such as contacting patients or booking additional appointments.,Pretransplant preparation individually by att
The Physician-nurse coordinator (PNC) system,Standard care

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adult patients (aged more than 18 years) diagnosed with MM who are transplant eligible 2. Underwent auto-HCT during January 2021-December 2022 in historical cohort 3. Underwent auto-HCT since Janurary 2023 in prospective cohort

Exclusion criteria

Exclusion criteria: 1. MM patients who declined transplantation 2. Severe cardiac dysfunction, defined as left ventricular ejection fraction < 40% 3. Extensive dental pathology (eg, multiple active caries) requiring prolonged treatment

Design outcomes

Primary

MeasureTime frame
Time to HCT at admission of transplantation Time from multiple myeloma diagnosis to date of admission for transplantation

Secondary

MeasureTime frame
time from stem cell collection to transplantation at admission of transplantation time from stem cell collection to transplantation,interval from stem cell collection to completion of pretransplant evaluations completion of pretransplant evaluation interval from stem cell collection to completion of pretransplant evaluations,relapse rate before transplantation at admission of transplantation relapse rate

Countries

Thailand

Contacts

Public ContactKanittha Yuphet

Faculty of Medicine, Siriraj Hospital

kanajung_tt@hotmail.com6624197642

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026